Related Experiment Videos
Interleukin-1beta stimulates phospholipase A2 activity in adult rat ventricular myocytes
1Department of Pathology, University of Arkansas for Medical Sciences, Little Rock 72205, USA.
Insights
Interleukin-1beta (IL-1beta) activates calcium-independent phospholipase A2 (PLA2) in rat heart cells. This inflammatory pathway increases arachidonic acid release, impacting cardiac function.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Interleukin-1beta (IL-1beta) is a key inflammatory cytokine.
- Phospholipase A2 (PLA2) enzymes play critical roles in cellular signaling and inflammation.
- The specific role of IL-1beta in modulating PLA2 activity in ventricular myocytes is not fully understood.
Purpose of the Study:
- To investigate the effect of IL-1beta on phospholipase A2 (PLA2) activity in rat ventricular myocytes.
- To determine the specific type and localization of PLA2 modulated by IL-1beta.
- To elucidate the signaling pathway involved in IL-1beta-induced PLA2 activation.
Main Methods:
- Measurement of PLA2 activity in isolated membrane and cytosol fractions using radiolabeled substrates.
- Assessment of arachidonic acid release.
- Use of a selective Ca2+-independent PLA2 inhibitor (E-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one).
- Application of IL-1 receptor antagonist (IL-1RA).
Main Results:
- IL-1beta significantly increased membrane-associated PLA2 activity in a Ca2+-independent manner.
- IL-1beta exposure led to increased arachidonic acid release.
- A selective Ca2+-independent PLA2 inhibitor blocked IL-1beta-induced effects.
- IL-1RA inhibited the IL-1beta-mediated increase in PLA2 activity, confirming receptor involvement.
Conclusions:
- IL-1beta, through its receptors, specifically stimulates membrane-associated, Ca2+-independent, plasmalogen-selective PLA2 in rat ventricular myocytes.
- This activation contributes to increased arachidonic acid release, suggesting a role in cardiac inflammatory processes.
- Findings highlight a novel IL-1beta-mediated signaling pathway in cardiomyocytes.
Abstract:
We have examined whether interleukin (IL)-1beta modulates phospholipase A2 (PLA2) activity in ventricular myocytes. PLA2 activity was measured in isolated membrane and cytosol fractions with (16:0,[3H]18:1) plasmenylcholine and (16:0,[3H]18:1) phosphatidylcholine in the absence and presence of Ca2+. When measured in the absence of Ca2+ with plasmenylcholine, exposure to 5 ng/ml IL-1beta caused an increase in membrane-associated PLA2 activity for 10 min that returned to basal levels by 20 min. In the presence of Ca2+ with phosphatidylcholine, IL-1beta had no effect on membrane-associated PLA2 but decreased cytosolic PLA2 activity. Additionally, IL-1beta caused an increase in arachidonic acid release in 20 min. Pretreatment with E-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one, a selective Ca2+-independent PLA2 inhibitor, blocked IL-1beta-induced increases in both PLA2 activity and arachidonic acid release. Exposure to IL-1 receptor antagonist (IL-1RA) alone had no effect on membrane-associated PLA2 activity. When incubated with IL-1beta, IL-1RA inhibited the IL-1beta-enhanced PLA2 activity. These results show that, via activation of its receptors, IL-1beta stimulates specifically membrane-associated Ca2+-independent plasmalogen-selective PLA2 in rat ventricular myocytes.